SPIMACO’s Morocco affiliate approves capital raise
The capital hike aims to complete the financing of the industrial project in Morocco’s Barshid city
By Staff Writer, Mubasher
Riyadh - The Saudi Pharmaceutical Industries and Medical Appliances Corp (SPIMACO) said the extraordinary assembly of its 70.65%-owned subsidiary, SPIMACO Morocco for Pharmaceutical Industries, approved increasing the company’s capital to MAD 582.161 million from MAD 470 million.
SPIMACO will contribute to the capital raise through capitalising the previously-granted shareholders’ loan of MAD 47.332 million and will provide cash contribution for the remaining amount that will be determined later on by the company’s board, according to a bourse filing on Tuesday.
The capital hike aims to complete the financing of the industrial project in Morocco’s Barshid city.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.